References
- Kim H, Rhee SH, Pothoulakis C, Lamont JT. 2007. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand. Gastroenterology 133: 875-886. https://doi.org/10.1053/j.gastro.2007.06.063
- Kim H, Kokkotou E, Na X, Rhee SH, Moyer MP, Pothoulakis C, et al. 2005. Clostridium difficile toxin A-induced colonocyte apoptosis involves pp.53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology 129: 1875-1888. https://doi.org/10.1053/j.gastro.2005.09.011
- Kim H, Rhee SH, Kokkotou E, Na X, Savidge T, Moyer MP, et al. 2005. Clostridium difficile toxin a regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J. Biol. Chem. 280: 21237-21245. https://doi.org/10.1074/jbc.M413842200
- He D, Sougioultzis S, Hagen S, Liu J, Keates S, Keates AC, et al. 2002. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 122: 1048-1057. https://doi.org/10.1053/gast.2002.32386
- Kim DH, Hwang JS, Lee IH, Nam ST, Hong J, Zhang P, et al. 2016. The insect peptide CopA3 increases colonic epithelial cell proliferation and mucosal barrier function to prevent inflammatory responses in the gut. J. Biol. Chem. 291: 3209-3223. https://doi.org/10.1074/jbc.M115.682856
- Chumbler NM, Farrow MA, Lapierre LA, Franklin JL, Lacy DB. 2016. Clostridium difficile toxins TcdA and TcdB cause colonic tissue damage by distinct mechanisms. Infect. Immun. 84: 2871-2877. https://doi.org/10.1128/IAI.00583-16
- Kim DH, Lee IH, Nam ST, Nam HJ, Kang JK, Seok H, et al. 2014. Effect of antisera from Clostridium difficile-infected mice on toxin-A-induced colonic epithelial cell death signaling. J. Microbiol. Biotechnol. 24: 696-703. https://doi.org/10.4014/jmb.1401.01059
- Subauste MC, Von Herrath M, Benard V, Chamberlain CE, Chuang TH, Chu K, et al. 2000. Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas. J. Biol. Chem. 275: 9725-9733. https://doi.org/10.1074/jbc.275.13.9725
- Robb CT, McSorley HJ, Lee J, Aoki T, Yu C, Crittenden S, et al. 2018. Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis. J. Allergy Clin. Immunol. 141: 152-162. https://doi.org/10.1016/j.jaci.2017.04.045
- Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ, et al. 2008. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann. Neurol. 64: 304-314. https://doi.org/10.1002/ana.21437
- Huang WT, Niu KC, Chang CK, Lin MT, Chang CP. 2008. Curcumin inhibits the increase of glutamate, hydroxyl radicals and PGE2 in the hypothalamus and reduces fever during LPS-induced systemic inflammation in rabbits. Euro. J. Pharm. 593: 105-111. https://doi.org/10.1016/j.ejphar.2008.07.017
- Turull N, Queralt J. 2000. Effect of the COX-2 selective inhibitor l-745,337 on inflammation and organ prostaglandin E2 (PGE2) levels in adjuvant arthritic rats. Inflammation 24: 533-545. https://doi.org/10.1023/A:1007025423232
- Lalier L, Pedelaborde F, Braud C, Menanteau J, Vallette FM, Olivier C. 2011. ncrease in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell. BMC Cancer 11: 153. https://doi.org/10.1186/1471-2407-11-153
- Wu L, Wang Q, Liang X, Andreasson K. 2007. Divergent effects of prostaglandin receptor signaling on neuronal survival. Neurosci. Lett. 421: 253-258. https://doi.org/10.1016/j.neulet.2007.05.055
- Huang SK, White ES, Wettlaufer SH, Grifka H, Hogaboam CM, Thannickal VJ, et al. 2009. Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J. 23: 4317-4326. https://doi.org/10.1096/fj.08-128801
- Pica F, Franzese O, D'Onofrio C, Bonmassar E, Favalli C, Garaci E. 1996. Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Mycdependent and Bcl-2-independent associated pathway. J. Pharmacol. Exp. Ther. 277: 1793-1800.
- Krajewska M, Fenoglio-Preiser CM, Krajewski S, Song K, Macdonald JS, Stemmerman G, et al. 1996. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am. J. Pathol. 149: 1449-1457.
- Krajewski S, Krajewska M, Reed JC. 1996. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res. 56: 2849-2855.
- Pataer A, Fang B, Yu R, Kagawa S, Hunt KK, McDonnell TJ, et al. 2000. Adenoviral Bak overexpression mediates caspasedependent tumor killing. Cancer Res. 60: 788-792.
- Hass R, Busche R, Luciano L, Reale E, Engelhardt WV. 1997. Lack of butyrate is associated with induction of Bax and subsequent apoptosis in the proximal colon of guinea pig. Gastroenterology 112: 875-881. https://doi.org/10.1053/gast.1997.v112.pm9041249
- Westphal D, Dewson G, Czabotar PE, Kluck RM. 2011. Molecular biology of Bax and Bak activation and action. Biochimica et Biophysica Acta 1813: 521-531. https://doi.org/10.1016/j.bbamcr.2010.12.019
- Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, et al. 1995. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736-739. https://doi.org/10.1038/374736a0
- Sullivan NM, Pellett S, Wilkins TD. 1982. Purification and characterization of toxins A and B of Clostridium difficile. Infect. Immun. 35: 1032-1040. https://doi.org/10.1128/IAI.35.3.1032-1040.1982
- Nakayama H, Yokoi H, Fujita J. 1992. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res. 20: 4939. https://doi.org/10.1093/nar/20.18.4939
- Yoon IN, Hwang JS, Lee JH, Kim H. 2019. The antimicrobial peptide CopA3 inhibits Clostridium difficile toxin a-induced viability loss and apoptosis in neural cells. J. Microbiol. Biotechnol. 29: 30-36. https://doi.org/10.4014/jmb.1809.08065
- Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, et al. 1996. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 39: 684-689. https://doi.org/10.1136/gut.39.5.684
- Martinou I, Desagher S, Eskes R, Antonsson B, Andre E, Fakan S, et al. 1999. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J. Cell Biol. 144: 883-889. https://doi.org/10.1083/jcb.144.5.883
- Lim ML, Lum MG, Hansen TM, Roucou X, Nagley P. 2002. On the release of cytochrome c from mitochondria during cell death signaling. J. Biomed. Sci. 9: 488-506. https://doi.org/10.1159/000064722
- Priault M, Chaudhuri B, Clow A, Camougrand N, Manon S. 1999. Investigation of bax-induced release of cytochrome c from yeast mitochondria permeability of mitochondrial membranes, role of VDAC and ATP requirement. Euro. J. Biochem. 260: 684-691. https://doi.org/10.1046/j.1432-1327.1999.00198.x
- Heimlich G, McKinnon AD, Bernardo K, Brdiczka D, Reed JC, Kain R, et al. 2004. Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6. Biochem. J. 378: 247-255. https://doi.org/10.1042/bj20031152
- Thornborrow EC, Manfredi JJ. 2001. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. J. Biol. Chem. 276: 15598-15608. https://doi.org/10.1074/jbc.M011643200
- Baltaziak M, Koda M, Wincewicz A, Sulkowska M, Kanczuga-Koda L, Sulkowski S. 2009. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer. Anticancer Res. 29: 4151-4156.
- Fortuno MA, Zalba G, Ravassa S, D'Elom E, Beaumont FJ, Fortuno A, et al. 1999. p53-mediated upregulation of BAX gene transcription is not involved in Bax-alpha protein overexpression in the left ventricle of spontaneously hypertensive rats. Hypertension 33: 1348-1352. https://doi.org/10.1161/01.HYP.33.6.1348
- Kong X, Xu P, Cai WJ, Wang HG, Li BB, Huang GL, et al. 2018. ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells. BMC Cancer 18: 419. https://doi.org/10.1186/s12885-018-4349-y
- Asboth G, Phaneuf S, Europe-Finner GN, Toth M, Bernal AL. 1996. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes. Endocrinology 137: 2572-2579. https://doi.org/10.1210/endo.137.6.8641211
- Rojas A, Gueorguieva P, Lelutiu N, Quan Y, Shaw R, Dingledine R. 2014. The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus. Neurobiol. Dis. 70: 74-89. https://doi.org/10.1016/j.nbd.2014.06.004
- Irie A, Sugimoto Y, Namba T, Asano T, Ichikawa A, Negishi M. 1994. The C-terminus of the prostaglandin-E-receptor EP3 subtype is essential for activation of GTP-binding protein. Euro. J. Biochem. 224: 161-166. https://doi.org/10.1111/j.1432-1033.1994.tb20007.x
- Soares AS, Costa VM, Diniz C, Fresco P. 2015. Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways. Basic Clin. Pharmacol. Toxicol. 116: 25-36. https://doi.org/10.1111/bcpt.12280
- Panaretakis T, Laane E, Pokrovskaja K, Bjorklund AC, Moustakas A, Zhivotovsky B, et al. 2005. Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis. Mol. Biol. Cell 16: 3821-3831. https://doi.org/10.1091/mbc.e04-10-0862
- Meinhardt G, Roth J, Totok G. 2000. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways. Euro. J. Cell Biol. 79: 824-833. https://doi.org/10.1078/0171-9335-00100
- Chen X, Lv Q, Ma J, Liu Y. 2018. PLC gamma2 promotes apoptosis while inhibits proliferation in rat hepatocytes through PKCD/JNK MAPK and PKCD/p38 MAPK signalling. Cell Prolif. 51: e12437. https://doi.org/10.1111/cpr.12437